BCX10013

DB18496InvestigationalSmall molecule

BCX10013 is a small molecule inhibitor of human complement factor D.

Code names
BCX-10013

What you can answer from here — as of September 28, 2023

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of BCX10013, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In